Nesta is a non-profit innovation foundation based in the United Kingdom, established in 1998. The organization is dedicated to supporting new ideas that address significant societal challenges. Through its initiatives and partnerships, Nesta seeks to identify, develop, and implement powerful solutions that can transform how society functions. In addition to its foundational work, Nesta Ventures operates as the venture capital arm of Nesta, focusing on investments in seed, startup, early-stage, growth, and expansion companies. Nesta Ventures invests in a variety of structures, including registered charities and private companies, with a particular emphasis on technology sectors such as engineering, healthcare, and cleantech. The firm typically acts as a lead investor or participates in syndicates, often taking board seats in its portfolio companies. It also invests in early-stage funds as a limited partner or co-investor but does not provide grants. Overall, Nesta aims to foster innovation and creativity to enhance societal well-being.
Oxford Medical Products is developing a safe, effective and affordable breakthrough technology for weight loss that uses a self-expanding capsule which occupies space in the stomach, reducing hunger and leading to significant weight loss. Led by a team of scientists, medical professionals, and entrepreneurs who have come together to solve one of the world’s toughest and most urgent medical challenges.
Developer of a careers mapping platform intended to help users discover and get into a future-proofed career. The company's platform uses comparative judgment through the use of artificial intelligence where users explore careers based on their interests, qualifications, and skills, enabling users to improve their efficiency and effectiveness of guidance sessions, and providing data and analysis to make a more informed decision.
We address the increasing need to hold organisations and governments to account for injustices that often impact thousands of individuals, from human rights abuses to privacy breaches. Seeking justice as an individual is daunting and often unattainable. Glow provides a central hub for victims of injustices to unite and take action. Whether you want to run a campaign, lobby for change or pursue legal action, Glow gives you the means to do so. We also provide legal professionals with comprehensive tools to efficiently manage group cases, from instigation through to resolution. When we come together we are stronger. Individuals and institutions that were always considered too powerful to hold to account take note, you will no longer be able to intimidate the underdog.
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.
Franklin Scholars is a social enterprise, and reinvests the majority of its profits to achieve sustainability, grow its reach and ensure the fulfilment of its mission.
Empathy Lab is an innovative organization dedicated to fostering children's empathy, literacy, and social activism through the strategic use of high-quality literature. By leveraging scientific research that highlights the importance of reading in developing real-life empathy skills, Empathy Lab implements programs aimed at enhancing emotional understanding among young readers. Additionally, the organization operates as a digital strategy agency, offering comprehensive services to Fortune 500 companies and rapidly growing businesses. With expertise in broadband video, e-commerce, and community-driven experiences, Empathy Lab has collaborated with notable clients in the media, entertainment, and eCommerce sectors. Their unique approach combines creative insight with a commitment to social impact, making them a leader in both educational and digital strategy fields.
Mind Moose is an online platform designed to support children's mental well-being and provide early intervention for mental health issues. Founded in 2016 and headquartered in Alderley Edge, Cheshire, United Kingdom, the platform integrates psychological research with animated character education to foster self-awareness and self-esteem among children. By focusing on enhancing social, mental, and emotional health, Mind Moose aims to equip children with essential skills such as resilience, problem-solving, and emotional control.
Voice 21 is a charity dedicated to promoting the value of oracy in education in the schools that need it most. We provide professional and leadership development, school improvement and curriculum resources for teachers and schools.
Children's University is an award winning, critically acclaimed, extra-curricular and informal learning programme which takes education outside the normal school day and environment.Children's University encourage 5-14 year olds to challenge themselves, to try new experiences, to develop new interests and acquire new skills. Delivered at a local level by local partners, Children’s University operates across the British Isles with 125 centres as well as internationally in at least 4 countries with a further 10 expressions of interest.
Swoop Finance Limited is a technology platform that specializes in business funding and savings solutions for small-to-medium enterprises. Founded in 2018 and headquartered in London, with additional offices in Ireland, Swoop connects businesses with a range of funding options, including loans, equity, and grants. The platform facilitates the discovery of appropriate funding solutions, allowing enterprises to streamline their financing needs and identify potential savings. Swoop operates as an Appointed Representative of Talbot Capital Limited, which is regulated by the Financial Conduct Authority.
Px HealthCare (Px) has developed the only validated, personalised medical support platform for cancer patients, called OWise, which has been demonstrated to improve the patient – physician relationship and is designed to improve users quality of life and even survival. Originally developed in the Netherlands, the award-winning mobile app ‘OWise breast cancer’ has been independently studied, revealing that 90% of the patients and 90% of the treating clinicians recommend OWise to breast cancer patients. With the widespread use of smartphones, OWise is designed to support patients as part of their everyday life during treatment. NHS England has selected OWise to be part of its Innovation Accelerator (2015) and it was listed in the Top25 of all health apps (by IQVIA, 2017). The focus is currently on breast cancer as so many women are affected by the condition and the impact, both mentally and physically, is big. Through the website (www.owise.nl / www.owise.eu) and the OWise smartphone app, Px HealthCare offers women (and men) smart internet tools which helps them gaining insight into and control over their situation during and after illness. Px HealthCare is a life sciences company, founded in 2012.
Citymart US Inc. offers a blend of training, research, and outreach to facilitate open challenges and gather innovative ideas from entrepreneurs and citizens to enhance urban problem-solving. Established in 2011 and headquartered in New York City, the company provides services that include formulating problem statements, launching open challenges, and engaging communities in the selection process of solutions. Citymart assists municipal employees by fostering a collaborative workflow for problem-based procurement and supplying market data on new solutions. Its methodology has been adopted by over 100 cities across 35 countries, addressing issues such as public lighting, traffic safety, and social cohesion, thereby improving the overall delivery of urban services.
Featurespace is the world-leader in Adaptive Behavioural Analytics and creator of the ARIC™ platform, a machine learning software system developed out of the University of Cambridge. The ARIC™ platform uses anomaly detection to analyse complex behavioural data in real time, spotting anomalies to block new fraud attacks as they occur. At the same time, Featurespace recognises genuine customers without blocking their activity. ARIC™ reduces the number of genuine transactions incorrectly identified as fraud by over 70%, enabling businesses to accept more revenue.
Head quartered in Cambridge, UK, and Atlanta, GA, U.S. Featurespace has deployed the ARIC™ platform to organisations that have services or products deployed in over 180 countries. Customers include Betfair, Vocalink/Zapp, Worldpay, and TSYS, the largest third-party processor of Visa® and MasterCard® credit cards in the U.S.
Radio Physics Solutions is a security and investigation company that specializes in the fields of real-time concealed threat detection, Up to 30m Distance, autonomous, and unobtrusive. It specializes in providing early warning of threats concealed under peoples’ clothes, and so reduce the number of casualties caused by terrorists and criminals globally at schools, train stations, airports, government and military installations, tourist attractions and entertainment venues. Radio Physics Solutions was founded in 2009 and headquartered in Cambridgeshire, United Kingdom.
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.
Plaxica Limited is a technology and licensing company that specializes in producing advanced biopolymers and platform chemicals derived from renewable resources. Founded in 2008 and headquartered in Redcar, United Kingdom, Plaxica offers a range of innovative products, including Optipure®, D Lactic Acid; Xylex®, Lignin Free Sugars; and Versalac®, Low Cost Lactic Acid technology. These biopolymers serve diverse applications, such as food packaging, drink bottles, furniture, automotive components, computer housings, carpets, and textiles. The company's focus on sustainability and renewable materials positions it as a leader in the development of environmentally friendly alternatives in various industries.
designLED Products specializes in the design and development of innovative LED lighting and Human-Machine Interface (HMI) products primarily for the automotive industry. Established in 2004, the company has gained international recognition for its advanced LED lighting system technologies. As the global lighting market expands, driven by government regulations and increasing consumer demand for energy-efficient and cost-effective solutions, designLED Products aims to transform perceptions of lighting products. By collaborating with strategic partners, the company focuses on delivering unique products, such as LED Light Tiles, to the international lighting design and engineering sectors, positioning itself as a leader in the evolving landscape of lighting technology.
Lein Applied Diagnostics is an optical metrology company pioneering measurement devices and solutions for the healthcare and industrial markets. Its core technology is based around a scanning confocal system that can make highly precise, non-contact dimensional and structural measurements of organic and man-made materials.
Lein was founded in 2003, initially to develop a non-invasive, pain free glucose meter for the diabetes market. Underpinning this Lein put together a highly qualified, experienced engineering team and built up a strong suite of patents.
Dialog Devices develops optical technologies to help meet the overwhelming demand for better healthcare. Its advanced opto-electronic technology is revolutionizing the way medical conditions are diagnosed and monitored; improving the health and well-being of people around the world. The company is also advancing additional applications for this technology including post-operative monitoring of peripheral interventions and diabetic neuropathy assessment.
Agilent Raman Spectroscopy’s proprietary technologies use novel variants of Raman spectroscopy. Their instruments can rapidly and accurately identify materials hidden inside objects or through opaque barriers such as plastic, coloured glass, paper and skin, or can measure the concentrations of materials in mixtures, with a high degree of accuracy. Agilent Raman Spectroscopy is formerly known as Cobalt Light Systems and is part of Agilent.
Ashe Morris
Venture Round in 2017
Ashe Morris is developing a heat transfer technology that helps improve the efficiency of industrial processes and reduce energy consumption.
Probe Scientific is developing innovative products to solve clinical problems and improve healthcare. The company has a substantial product pipeline based on its proprietary technologies and is seeking to commercialise this range to simultaneously benefit clinicians and the community in general. Probe Scientific Ltd is a private company, founded in 1998 and is based in the West Midlands, UK.
Probe Scientific has grown steadily since its origins as a research organisation and has recently recruited experienced senior executives with a commercial focus.
BaseKit is the most widely deployed website editor distributed by hosting, telco and internet companies.
Their hosting partners benefit from improved ARPU, reduced churn and higher customer satisfaction ratings. Supported configurations include On-premise, SaaS, cPanel plugin and Parallels APS. Their application and documentation is available in 16 languages.
ProKyma Technologies Limited specializes in diagnostics services and life science applications utilizing magnetic particles for various processes such as cell isolation, immunoassay, DNA capture, and blood grouping. Based in Salisbury, Wiltshire, United Kingdom, the company focuses on developing advanced cell separation technologies to enhance molecular biology tests, particularly for improving blood tests related to Circulating Tumour Cells (CTCs). This innovation aims to facilitate the early detection of cancer metastasis and monitor therapy responses. ProKyma emerged as a spinout from Dstl Porton Down, leveraging research in separation technologies, and employs high frequency ultrasound combined with magnetism to effectively manipulate, concentrate, and purify biological cells from complex samples. Its techniques have applications across clinical, food, environmental, and pharmaceutical sectors.
eoSemi is an emerging privately-funded semiconductor product company based in South Yorkshire.
Shrinking electronic systems are placing significant pressure on traditional timing and frequency devices to reduce in size without compromising performance - something they cannot do easily or cheaply.
eoSemi is a new technological transformation. It meets head-on the challenges of size-vs-performance, with an enabling technology that allows for creation of far more compact designs, and that facilitates new classes of product and application.
Cytox Limited is focused on developing products and services aimed at addressing neurodegenerative disorders, particularly Alzheimer's disease (AD). The company specializes in cellular and genetic assays that facilitate the diagnosis and treatment of AD, leveraging the cell division cycle theory of its pathogenesis. It has created a genetic-based blood test designed for early-stage risk assessment and diagnosis of Alzheimer's disease. Cytox also offers biomarker and drug-screening services to pharmaceutical companies engaged in clinical trials for AD and mild cognitive impairment treatments. By collaborating with Affymetrix, a part of Thermo Fisher Scientific, Cytox supports the development of novel therapeutics aimed at combating this growing condition, which currently affects millions worldwide. Founded in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox serves a global clientele that includes pharmaceutical and biotechnology firms, as well as research laboratories.
Six to Start Limited specializes in creating alternate reality games that blend multiple media formats, such as the web, mobile devices, and live events, to engage players in interactive storytelling. Founded in 2007 and based in London, the company serves the entertainment and advertising industries by developing immersive game experiences that integrate digital and physical elements. In addition to game development, Six to Start offers consulting services, leveraging its expertise in gameplay and storytelling to enhance various projects. The company's innovative approach allows users to influence narratives in real time, making it a unique player in the gaming landscape.
Surface Generation is a privately-owned high technology and manufacturing company headquartered in the UK and with facilities in North America and Asia. Its patented Production to Functional Specification (PtFS) technology enables manufacturers in the aerospace, automotive and consumer electronics sectors to work with composite materials, saving costs, energy and producing significantly lighter weight products.
Camfridge Ltd is a UK-based company that specializes in developing low carbon cooling products for appliance manufacturers. Founded in 2003 and located in Cambridge, the company utilizes innovative magnetic cooling technology, which employs metal alloys and magnetic fields to create an energy-efficient cooling cycle. This technology aims to significantly reduce energy consumption and eliminates the need for polluting gases commonly used in traditional cooling systems. Camfridge has gained recognition in the clean technology sector, being selected as one of the top 100 private European clean technology companies in the Cleantech 100.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
Playmob is a games platform for brands with purpose. We connect the most meaningful brands to billions of mobile gamers, to take action and make the world a better place while positively boosting the brands bottom line. Through leveraging playable-ads with our unique impact methodology, harnessing media space within existing hit mobile titles and tracking powerful values-based data and business data, Playmob aims to be the first global distribution platform, enabling brands to reach and engage gamers with their purpose. Playmob also benefits the publisher by meaningfully engaging with the player. We see engagement rates of 30% to 50%.
Smart Surgical Appliances
Venture Round in 2017
Smart Surgical Appliances is a medical device company that develops sensor-enabled surgical instruments designed to reduce costs, improve safety, and minimize risk in keyhole surgery. The company intends to improve the safety and clinical efficacy of the minimally invasive surgery like keyhole surgery, endoscopic surgery, and the natural orifice transluminal endoscopic surgeries. It provide real-time sensing and feedback from the operative site akin to 'touch and feel'.
Orthogem Limited is a company based in Nottingham, United Kingdom, that specializes in the development and manufacture of synthetic bone grafts. Since its founding in 2001, Orthogem has leveraged its patented Tripore technology platform to create a diverse range of synthetic bone graft products suitable for various clinical applications, including spinal surgery and oral craniofacial procedures. The company's product lineup features TriPore Granules, TriPore MPA, and TriPore Blocks, which are designed to meet the needs of medical professionals in the field of orthopedic and reconstructive surgery.
CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutic products. Established in 2003, the company specializes in small-molecule inhibitors that target p300 and CBP proteins, as well as a deubiquitinase enzyme closely linked to prostate cancer. This enzyme modulates the androgen receptor pathway, which is critical in addressing resistance mechanisms encountered with existing prostate cancer treatments. CellCentric's therapies aim to treat various cancers, including castrate-resistant prostate cancer, lung cancer, bladder cancer, non-small cell lung cancer, breast cancer, and colon cancer. By targeting specific pathways and mechanisms, CellCentric seeks to provide effective treatment options for patients with challenging cancer types.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Featurespace is the world-leader in Adaptive Behavioural Analytics and creator of the ARIC™ platform, a machine learning software system developed out of the University of Cambridge. The ARIC™ platform uses anomaly detection to analyse complex behavioural data in real time, spotting anomalies to block new fraud attacks as they occur. At the same time, Featurespace recognises genuine customers without blocking their activity. ARIC™ reduces the number of genuine transactions incorrectly identified as fraud by over 70%, enabling businesses to accept more revenue.
Head quartered in Cambridge, UK, and Atlanta, GA, U.S. Featurespace has deployed the ARIC™ platform to organisations that have services or products deployed in over 180 countries. Customers include Betfair, Vocalink/Zapp, Worldpay, and TSYS, the largest third-party processor of Visa® and MasterCard® credit cards in the U.S.
Featurespace is the world-leader in Adaptive Behavioural Analytics and creator of the ARIC™ platform, a machine learning software system developed out of the University of Cambridge. The ARIC™ platform uses anomaly detection to analyse complex behavioural data in real time, spotting anomalies to block new fraud attacks as they occur. At the same time, Featurespace recognises genuine customers without blocking their activity. ARIC™ reduces the number of genuine transactions incorrectly identified as fraud by over 70%, enabling businesses to accept more revenue.
Head quartered in Cambridge, UK, and Atlanta, GA, U.S. Featurespace has deployed the ARIC™ platform to organisations that have services or products deployed in over 180 countries. Customers include Betfair, Vocalink/Zapp, Worldpay, and TSYS, the largest third-party processor of Visa® and MasterCard® credit cards in the U.S.
The Behavioural Insights Team is an organisation that was set up to apply nudge theory to try to improve government policy and services. The company itself has three owners: the employees, the UK government, and Nesta (the UK's leading innovation charity). Nesta were the winners of a highly competitive process to become the team's joint venture partners, and we're delighted to have them on board. They coined the term ‘behavioural insights’ in 2010 to help bring together ideas from a range of inter-related academic disciplines (behavioural economics, psychology, and social anthropology). These fields seek to understand how individuals take decisions in practice and how they are likely to respond to options. Their insights enable us to design policies or interventions that can encourage, support and enable people to make better choices for themselves and society.
BaseKit is the most widely deployed website editor distributed by hosting, telco and internet companies.
Their hosting partners benefit from improved ARPU, reduced churn and higher customer satisfaction ratings. Supported configurations include On-premise, SaaS, cPanel plugin and Parallels APS. Their application and documentation is available in 16 languages.
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Featurespace is the world-leader in Adaptive Behavioural Analytics and creator of the ARIC™ platform, a machine learning software system developed out of the University of Cambridge. The ARIC™ platform uses anomaly detection to analyse complex behavioural data in real time, spotting anomalies to block new fraud attacks as they occur. At the same time, Featurespace recognises genuine customers without blocking their activity. ARIC™ reduces the number of genuine transactions incorrectly identified as fraud by over 70%, enabling businesses to accept more revenue.
Head quartered in Cambridge, UK, and Atlanta, GA, U.S. Featurespace has deployed the ARIC™ platform to organisations that have services or products deployed in over 180 countries. Customers include Betfair, Vocalink/Zapp, Worldpay, and TSYS, the largest third-party processor of Visa® and MasterCard® credit cards in the U.S.
Playmob is a games platform for brands with purpose. We connect the most meaningful brands to billions of mobile gamers, to take action and make the world a better place while positively boosting the brands bottom line. Through leveraging playable-ads with our unique impact methodology, harnessing media space within existing hit mobile titles and tracking powerful values-based data and business data, Playmob aims to be the first global distribution platform, enabling brands to reach and engage gamers with their purpose. Playmob also benefits the publisher by meaningfully engaging with the player. We see engagement rates of 30% to 50%.
Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces.
Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.
Skimlinks is the leading commerce content monetization platform, supporting publishers’ creation of a new revenue stream that allows them to be less dependent on advertising. Commerce can contribute as much as a quarter of publishers’ overall revenue. Skimlinks technology automatically earns publishers a share of sales they drive through monetized product links in commerce-related content. These links generate revenue when clicked on by readers who go on to make a purchase as a result. In its platform, Skimlinks offers a growing suite of innovative solutions designed to increase the number of clicks and earnings per click of commerce-related content. It also aggregates access for publishers to over 60 affiliate networks, enabling them to earn commission from 27,000 merchants around the world instantly. Annual ecommerce transactions in Skimlinks’ network totalled $1 billion in 2017. Clients include over half of the top 100 US & UK publishers by revenue including Conde Nast, Hearst, Buzzfeed, Huffington Post, Trinity Mirror, MailOnline, and more.
Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces.
Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.
They believe that conventional diabetes care technology is stuck in the past, and that it has failed to put first the needs and wants of patients who have to live with the condition and the daily demands of its treatment. Those with diabetes should be put back in control, and they should live a life that is as unaffected as possible by the need to manage their condition.
The experience of managing diabetes should be as positive as possible. Thoughtful and innovative design should make things easier to understand and simpler to use. With belief in these ideals, they tore up convention. When they started, they did so with a focus only on how modern technology and beautiful design would make life easier for someone managing diabetes.
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces.
Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.
eoSemi is an emerging privately-funded semiconductor product company based in South Yorkshire.
Shrinking electronic systems are placing significant pressure on traditional timing and frequency devices to reduce in size without compromising performance - something they cannot do easily or cheaply.
eoSemi is a new technological transformation. It meets head-on the challenges of size-vs-performance, with an enabling technology that allows for creation of far more compact designs, and that facilitates new classes of product and application.
BaseKit is the most widely deployed website editor distributed by hosting, telco and internet companies.
Their hosting partners benefit from improved ARPU, reduced churn and higher customer satisfaction ratings. Supported configurations include On-premise, SaaS, cPanel plugin and Parallels APS. Their application and documentation is available in 16 languages.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
Skimlinks is the leading commerce content monetization platform, supporting publishers’ creation of a new revenue stream that allows them to be less dependent on advertising. Commerce can contribute as much as a quarter of publishers’ overall revenue. Skimlinks technology automatically earns publishers a share of sales they drive through monetized product links in commerce-related content. These links generate revenue when clicked on by readers who go on to make a purchase as a result. In its platform, Skimlinks offers a growing suite of innovative solutions designed to increase the number of clicks and earnings per click of commerce-related content. It also aggregates access for publishers to over 60 affiliate networks, enabling them to earn commission from 27,000 merchants around the world instantly. Annual ecommerce transactions in Skimlinks’ network totalled $1 billion in 2017. Clients include over half of the top 100 US & UK publishers by revenue including Conde Nast, Hearst, Buzzfeed, Huffington Post, Trinity Mirror, MailOnline, and more.
Lein Applied Diagnostics is an optical metrology company pioneering measurement devices and solutions for the healthcare and industrial markets. Its core technology is based around a scanning confocal system that can make highly precise, non-contact dimensional and structural measurements of organic and man-made materials.
Lein was founded in 2003, initially to develop a non-invasive, pain free glucose meter for the diabetes market. Underpinning this Lein put together a highly qualified, experienced engineering team and built up a strong suite of patents.
Plaxica Limited is a technology and licensing company that specializes in producing advanced biopolymers and platform chemicals derived from renewable resources. Founded in 2008 and headquartered in Redcar, United Kingdom, Plaxica offers a range of innovative products, including Optipure®, D Lactic Acid; Xylex®, Lignin Free Sugars; and Versalac®, Low Cost Lactic Acid technology. These biopolymers serve diverse applications, such as food packaging, drink bottles, furniture, automotive components, computer housings, carpets, and textiles. The company's focus on sustainability and renewable materials positions it as a leader in the development of environmentally friendly alternatives in various industries.
BaseKit is the most widely deployed website editor distributed by hosting, telco and internet companies.
Their hosting partners benefit from improved ARPU, reduced churn and higher customer satisfaction ratings. Supported configurations include On-premise, SaaS, cPanel plugin and Parallels APS. Their application and documentation is available in 16 languages.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Smart Surgical Appliances
Seed Round in 2009
Smart Surgical Appliances is a medical device company that develops sensor-enabled surgical instruments designed to reduce costs, improve safety, and minimize risk in keyhole surgery. The company intends to improve the safety and clinical efficacy of the minimally invasive surgery like keyhole surgery, endoscopic surgery, and the natural orifice transluminal endoscopic surgeries. It provide real-time sensing and feedback from the operative site akin to 'touch and feel'.
Skimlinks is the leading commerce content monetization platform, supporting publishers’ creation of a new revenue stream that allows them to be less dependent on advertising. Commerce can contribute as much as a quarter of publishers’ overall revenue. Skimlinks technology automatically earns publishers a share of sales they drive through monetized product links in commerce-related content. These links generate revenue when clicked on by readers who go on to make a purchase as a result. In its platform, Skimlinks offers a growing suite of innovative solutions designed to increase the number of clicks and earnings per click of commerce-related content. It also aggregates access for publishers to over 60 affiliate networks, enabling them to earn commission from 27,000 merchants around the world instantly. Annual ecommerce transactions in Skimlinks’ network totalled $1 billion in 2017. Clients include over half of the top 100 US & UK publishers by revenue including Conde Nast, Hearst, Buzzfeed, Huffington Post, Trinity Mirror, MailOnline, and more.
Camrivox Ltd offers customers simple and effective Telephony Integration with CRM. The company has pioneered the development and delivery of Flexor Software, greatly simplifying CRM Telephony Integration that has traditionally relied upon large investments in infrastructure, hardware and support staff. With Flexor Software uniquely delivered and supported at the PC level, companies can bypass this resource-laden route, improving business processes and increasing customer satisfaction. Camrivox, founded in 2005, is headquartered in Cambridge, UK.
Skimlinks is the leading commerce content monetization platform, supporting publishers’ creation of a new revenue stream that allows them to be less dependent on advertising. Commerce can contribute as much as a quarter of publishers’ overall revenue. Skimlinks technology automatically earns publishers a share of sales they drive through monetized product links in commerce-related content. These links generate revenue when clicked on by readers who go on to make a purchase as a result. In its platform, Skimlinks offers a growing suite of innovative solutions designed to increase the number of clicks and earnings per click of commerce-related content. It also aggregates access for publishers to over 60 affiliate networks, enabling them to earn commission from 27,000 merchants around the world instantly. Annual ecommerce transactions in Skimlinks’ network totalled $1 billion in 2017. Clients include over half of the top 100 US & UK publishers by revenue including Conde Nast, Hearst, Buzzfeed, Huffington Post, Trinity Mirror, MailOnline, and more.
Dexela develops a 3-D breast imaging technology for the early detection of breast cancer. It offers DexTop Digital Mammography Workstation, a screening workstation that ensures screening workflow and performance; and Dexela 3D reconstruction engine that is offered to OEM partners as a software module with licensing terms. The company provides flat panel CMOS X-ray detectors that are used in various medical applications, including mammography and tomosynthesis, breast CT, dental CBCT, fluoroscopy, cardiology and angiographic imaging, and bone densitometry, as well as in scientific instrumentation and non-destructive testing applications. It also offers consulting services in the areas of digital tomosynthesis, mammography acquisition geometry, and optimal reconstruction of 3D data; and design and implementation resources for hardware and software engineering projects. Dexela Limited was incorporated in 2003 and is based in London, the United Kingdom. It has an X-ray research and development facility in Sudbury, Massachusetts.
MMIC Solutions is deploying technology to allow the commercial use of high frequencies in the millimeter wave bands. The company develops, manufactures, and supplys innovative solutions for a range of systems operating at frequencies between 50GHz and 250GHz
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Micrima Ltd. spun out from research at the University of Bristol. The Micrima team is developnig radio-wave technology for detecting breast cancer. The technology is non-invasive, non-ionising and inexpensive.
The imaging technology has received extensive validation in the laboratory and is now undergoing first human use trials.
Gnodal was founded in 2007 by a world-class team of IT infrastructure design experts with a proven track record for delivering best-of-breed networking systems that meet the demands of their customers. The team's experience and collaborative spirit in working together on design, manufacture and deployment, has led to the definition of a technology that is revolutionizing the data center. Gnodal is building the largest, fastest, most efficient and scalable technology in the world for the high performance data center.
ProVision was founded by two university professors, each renowned in the wireless and video fields as world experts. This gives ProVision a unique technological advantage. As a result the company is able to create products that reliably display HD video, regardless of fluctuations in the wireless signal caused by people moving within the home, and the size and structure of the home. ProVision’s two main technology platforms are AXAR, a system for all-room wireless distribution of HDTV to televisions in homes, and ProMultiVu, a technology for multi-cast video transmission at outdoor events. ProMultiVu transmissions are typically received by laptop PCs, PDAs or smart phones.
They believe that conventional diabetes care technology is stuck in the past, and that it has failed to put first the needs and wants of patients who have to live with the condition and the daily demands of its treatment. Those with diabetes should be put back in control, and they should live a life that is as unaffected as possible by the need to manage their condition.
The experience of managing diabetes should be as positive as possible. Thoughtful and innovative design should make things easier to understand and simpler to use. With belief in these ideals, they tore up convention. When they started, they did so with a focus only on how modern technology and beautiful design would make life easier for someone managing diabetes.
CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutic products. Established in 2003, the company specializes in small-molecule inhibitors that target p300 and CBP proteins, as well as a deubiquitinase enzyme closely linked to prostate cancer. This enzyme modulates the androgen receptor pathway, which is critical in addressing resistance mechanisms encountered with existing prostate cancer treatments. CellCentric's therapies aim to treat various cancers, including castrate-resistant prostate cancer, lung cancer, bladder cancer, non-small cell lung cancer, breast cancer, and colon cancer. By targeting specific pathways and mechanisms, CellCentric seeks to provide effective treatment options for patients with challenging cancer types.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.
MMIC Solutions is deploying technology to allow the commercial use of high frequencies in the millimeter wave bands. The company develops, manufactures, and supplys innovative solutions for a range of systems operating at frequencies between 50GHz and 250GHz
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutic products. Established in 2003, the company specializes in small-molecule inhibitors that target p300 and CBP proteins, as well as a deubiquitinase enzyme closely linked to prostate cancer. This enzyme modulates the androgen receptor pathway, which is critical in addressing resistance mechanisms encountered with existing prostate cancer treatments. CellCentric's therapies aim to treat various cancers, including castrate-resistant prostate cancer, lung cancer, bladder cancer, non-small cell lung cancer, breast cancer, and colon cancer. By targeting specific pathways and mechanisms, CellCentric seeks to provide effective treatment options for patients with challenging cancer types.
Micrima Ltd. spun out from research at the University of Bristol. The Micrima team is developnig radio-wave technology for detecting breast cancer. The technology is non-invasive, non-ionising and inexpensive.
The imaging technology has received extensive validation in the laboratory and is now undergoing first human use trials.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.
CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutic products. Established in 2003, the company specializes in small-molecule inhibitors that target p300 and CBP proteins, as well as a deubiquitinase enzyme closely linked to prostate cancer. This enzyme modulates the androgen receptor pathway, which is critical in addressing resistance mechanisms encountered with existing prostate cancer treatments. CellCentric's therapies aim to treat various cancers, including castrate-resistant prostate cancer, lung cancer, bladder cancer, non-small cell lung cancer, breast cancer, and colon cancer. By targeting specific pathways and mechanisms, CellCentric seeks to provide effective treatment options for patients with challenging cancer types.
Water Innovate focuses on bridging the gap between research and industry innovation in the water and environmental sectors. The company specializes in the development and commercialization of advanced water and wastewater treatment technologies. By evaluating new technologies and investing resources in their development, Water Innovate effectively identifies routes to market. Their portfolio includes a variety of cutting-edge products designed by leading experts in the field, aimed at addressing the challenges faced by the water industry. These technologies are systematically transferred from research laboratories to the marketplace, facilitating practical solutions for the international water and environmental sectors.
NanoSight, established in 2002, specializes in the development of instruments for the optical detection and real-time analysis of sub-micron particles. Founded by Bob Carr, the company leverages a suite of patented technologies to provide unique solutions that surpass traditional light scattering methods. Its instrumentation and software facilitate multi-parameter analysis and characterization of various nanoscale particles, positioning NanoSight as a leading provider in this specialized field. The company’s innovative approach offers significant advantages for researchers and industries requiring precise measurement and understanding of nanoparticles.
Tideway Systems provides a shared platform for technologists to visualize and report on the data they need to make informed decisions. Tideway Foundation software continuously maps application relationships to physical and virtual infrastructure, including the dependencies between them.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.